Cargando…
Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data
SARS-CoV-2 infection after vaccination can occur because COVID-19 vaccines do not offer 100% protection. The study aim was to assess duration of vaccination coverage, disease symptoms and type of hospitalization among non-vaccinated and vaccinated subjects to evaluate the vaccination trend over time...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222607/ https://www.ncbi.nlm.nih.gov/pubmed/35742137 http://dx.doi.org/10.3390/healthcare10061085 |
_version_ | 1784732907526422528 |
---|---|
author | Perrella, Alessandro Bisogno, Massimo D’Argenzio, Angelo Trama, Ugo Coscioni, Enrico Orlando, Valentina |
author_facet | Perrella, Alessandro Bisogno, Massimo D’Argenzio, Angelo Trama, Ugo Coscioni, Enrico Orlando, Valentina |
author_sort | Perrella, Alessandro |
collection | PubMed |
description | SARS-CoV-2 infection after vaccination can occur because COVID-19 vaccines do not offer 100% protection. The study aim was to assess duration of vaccination coverage, disease symptoms and type of hospitalization among non-vaccinated and vaccinated subjects to evaluate the vaccination trend over time. A retrospective cohort study was carried out among people testing COVID-19 positive in Campania Region using information from the Health Information System of Campania Region (Sinfonia). Vaccination status was assessed considering: no vaccination, partial vaccination and effective vaccination. Univariate and multivariate logistic regression models were constructed to evaluate the association between ICU admissions caused by COVID-19 and gender, age groups and vaccine type. Vaccine coverage duration trends were investigated using segmented linear regression and breakpoint estimations. Vaccination coverage was assessed by analyzing COVID-19 positive subjects in the 9 months after an effective dose vaccination. A significant risk of hospitalization in the ICU was caused by vaccination status: subjects non-vaccinated (OR: 7.14) and partially vaccinated (OR: 3.68) were 3 and 7 times more at risk of hospitalization, respectively, than subjects effectively vaccinated. Regarding subjects with an effective vaccination, the vaccine’s ability to protect against infection in the months following vaccination decreased. The risk of contracting COVID-19 after vaccination was higher 5 months (β = 1441, p < 0.001) and 7 months (β = 3110, p < 0.001) after administration of an effective dose. COVID-19 vaccines were demonstrated to protect from symptomatic infection by significantly reducing hospitalization risk, and their full protection against SARS-CoV-2 was demonstrated to decrease after 5 months regardless of age, gender or vaccine type. |
format | Online Article Text |
id | pubmed-9222607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92226072022-06-24 Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data Perrella, Alessandro Bisogno, Massimo D’Argenzio, Angelo Trama, Ugo Coscioni, Enrico Orlando, Valentina Healthcare (Basel) Article SARS-CoV-2 infection after vaccination can occur because COVID-19 vaccines do not offer 100% protection. The study aim was to assess duration of vaccination coverage, disease symptoms and type of hospitalization among non-vaccinated and vaccinated subjects to evaluate the vaccination trend over time. A retrospective cohort study was carried out among people testing COVID-19 positive in Campania Region using information from the Health Information System of Campania Region (Sinfonia). Vaccination status was assessed considering: no vaccination, partial vaccination and effective vaccination. Univariate and multivariate logistic regression models were constructed to evaluate the association between ICU admissions caused by COVID-19 and gender, age groups and vaccine type. Vaccine coverage duration trends were investigated using segmented linear regression and breakpoint estimations. Vaccination coverage was assessed by analyzing COVID-19 positive subjects in the 9 months after an effective dose vaccination. A significant risk of hospitalization in the ICU was caused by vaccination status: subjects non-vaccinated (OR: 7.14) and partially vaccinated (OR: 3.68) were 3 and 7 times more at risk of hospitalization, respectively, than subjects effectively vaccinated. Regarding subjects with an effective vaccination, the vaccine’s ability to protect against infection in the months following vaccination decreased. The risk of contracting COVID-19 after vaccination was higher 5 months (β = 1441, p < 0.001) and 7 months (β = 3110, p < 0.001) after administration of an effective dose. COVID-19 vaccines were demonstrated to protect from symptomatic infection by significantly reducing hospitalization risk, and their full protection against SARS-CoV-2 was demonstrated to decrease after 5 months regardless of age, gender or vaccine type. MDPI 2022-06-10 /pmc/articles/PMC9222607/ /pubmed/35742137 http://dx.doi.org/10.3390/healthcare10061085 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Perrella, Alessandro Bisogno, Massimo D’Argenzio, Angelo Trama, Ugo Coscioni, Enrico Orlando, Valentina Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data |
title | Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data |
title_full | Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data |
title_fullStr | Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data |
title_full_unstemmed | Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data |
title_short | Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data |
title_sort | risk of sars-cov-2 infection breakthrough among the non-vaccinated and vaccinated population in italy: a real-world evidence study based on big data |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222607/ https://www.ncbi.nlm.nih.gov/pubmed/35742137 http://dx.doi.org/10.3390/healthcare10061085 |
work_keys_str_mv | AT perrellaalessandro riskofsarscov2infectionbreakthroughamongthenonvaccinatedandvaccinatedpopulationinitalyarealworldevidencestudybasedonbigdata AT bisognomassimo riskofsarscov2infectionbreakthroughamongthenonvaccinatedandvaccinatedpopulationinitalyarealworldevidencestudybasedonbigdata AT dargenzioangelo riskofsarscov2infectionbreakthroughamongthenonvaccinatedandvaccinatedpopulationinitalyarealworldevidencestudybasedonbigdata AT tramaugo riskofsarscov2infectionbreakthroughamongthenonvaccinatedandvaccinatedpopulationinitalyarealworldevidencestudybasedonbigdata AT coscionienrico riskofsarscov2infectionbreakthroughamongthenonvaccinatedandvaccinatedpopulationinitalyarealworldevidencestudybasedonbigdata AT orlandovalentina riskofsarscov2infectionbreakthroughamongthenonvaccinatedandvaccinatedpopulationinitalyarealworldevidencestudybasedonbigdata |